510(k) K040290
K040290 is an FDA 510(k) premarket notification submitted by Diasorin S.P.A for the device "DIASORIN LIAISON CMV IGM/IGG". The FDA issued a decision of Substantially Equivalent on June 1, 2005. The device falls under product code LFZ (Enzyme Linked Immunoabsorbent Assay, Cytomegalovirus), a Class II device regulated under 21 CFR 866.3175. Diasorin S.P.A has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- June 1, 2005
- Date Received
- February 6, 2004
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Enzyme Linked Immunoabsorbent Assay, Cytomegalovirus
- Device Class
- Class II
- Regulation Number
- 866.3175
- Review Panel
- MI
- Submission Type